317 related articles for article (PubMed ID: 19416272)
1. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis.
Morioka T; Yamanaka K; Mori H; Omoto Y; Tokime K; Kakeda M; Kurokawa I; Gabazza EC; Tsubura A; Yasutomi Y; Mizutani H
Br J Dermatol; 2009 Jun; 160(6):1172-9. PubMed ID: 19416272
[TBL] [Abstract][Full Text] [Related]
2. Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells.
Mori H; Yamanaka K; Matsuo K; Kurokawa I; Yasutomi Y; Mizutani H
Arch Dermatol Res; 2009 Feb; 301(2):151-7. PubMed ID: 18633632
[TBL] [Abstract][Full Text] [Related]
3. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
4. Mutant interleukin-4/13 signaling blockade successfully suppresses acute phase inflammation.
Nakanishi T; Yamanaka K; Kakeda M; Tsuda K; Mizutani H
Arch Dermatol Res; 2013 Apr; 305(3):241-7. PubMed ID: 23179586
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
Katagiri K; Arakawa S; Hatano Y; Fujiwara S
Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
[TBL] [Abstract][Full Text] [Related]
6. Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis.
Kim ST; Lee KM; Park HJ; Jin SE; Ahn WS; Kim CK
J Gene Med; 2009 Jan; 11(1):26-37. PubMed ID: 19006098
[TBL] [Abstract][Full Text] [Related]
7. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
[TBL] [Abstract][Full Text] [Related]
8. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
9. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
Horiuchi Y; Bae S; Katayama I; Nishioka K
J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
[TBL] [Abstract][Full Text] [Related]
12. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
[TBL] [Abstract][Full Text] [Related]
13. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
14. Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse.
Chan CC; Liou CJ; Xu PY; Shen JJ; Kuo ML; Len WB; Chang LE; Huang WC
J Dermatol Sci; 2013 Nov; 72(2):149-57. PubMed ID: 23891346
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
16. Specific substance of Maruyama (SSM) suppresses immune responses in atopic dermatitis-like skin lesions in DS-Nh mice by modulating dendritic cell functions.
Mitsuishi T; Kabashima K; Tanizaki H; Ohsawa I; Oda F; Yamada Y; Halifu Y; Kawana S; Kato T; Iida K
J Dermatol Sci; 2011 Sep; 63(3):184-90. PubMed ID: 21708453
[TBL] [Abstract][Full Text] [Related]
17. Suppression of dust mite extract and 2,4-dinitrochlorobenzene-induced atopic dermatitis by the water extract of Lindera obtusiloba.
Choi EJ; Lee S; Kim HH; Singh TS; Choi JK; Choi HG; Suh WM; Lee SH; Kim SH
J Ethnopharmacol; 2011 Sep; 137(1):802-7. PubMed ID: 21762765
[TBL] [Abstract][Full Text] [Related]
18. Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice.
Wang G; Savinko T; Wolff H; Dieu-Nosjean MC; Kemeny L; Homey B; Lauerma AI; Alenius H
Clin Exp Allergy; 2007 Jan; 37(1):151-61. PubMed ID: 17210053
[TBL] [Abstract][Full Text] [Related]
19. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions.
Konishi H; Tsutsui H; Murakami T; Yumikura-Futatsugi S; Yamanaka K; Tanaka M; Iwakura Y; Suzuki N; Takeda K; Akira S; Nakanishi K; Mizutani H
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11340-5. PubMed ID: 12151598
[TBL] [Abstract][Full Text] [Related]
20. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
